Furthermore, the quantity of CD34+;αSMA+;CD31+ VECs correlates with clinical outcomes of progressive fibrotic remodeling, offering a novel cellular correlate for the interaction between vascular changes and fibrosis in SSc. The gene discussed is PECAM1; the disease is systemic sclerosis.